N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143252 |
| CAS No | NA |
| Mol.F. | C17H21ClN4O5 |
| Mol.Wt. | 396.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143253 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143254 |
| CAS No | NA |
| Mol.F. | C20H27ClN4O5 |
| Mol.Wt. | 438.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143255 |
| CAS No | NA |
| Mol.F. | C18H25BrN4O4 |
| Mol.Wt. | 441.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143256 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143257 |
| CAS No | NA |
| Mol.F. | C26H29Cl2N5O6 |
| Mol.Wt. | 578.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143258 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O7 |
| Mol.Wt. | 444.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143259 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143260 |
| CAS No | NA |
| Mol.F. | C18H23ClN4O4 |
| Mol.Wt. | 394.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143261 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O5 |
| Mol.Wt. | 272.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143262 |
| CAS No | NA |
| Mol.F. | C10H8BrClN2O5 |
| Mol.Wt. | 351.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143263 |
| CAS No | NA |
| Mol.F. | C26H37N3O6 |
| Mol.Wt. | 487.60g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143264 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143265 |
| CAS No | NA |
| Mol.F. | C18H29N3O6 |
| Mol.Wt. | 383.45g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143266 |
| CAS No | NA |
| Mol.F. | C19H33N3O6 |
| Mol.Wt. | 399.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143267 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |